Prostate cancer decisions — 2024

The Board has remanded the case due to inadequate reasons and bases for its decision denying a higher rating for prostate cancer from November 1, 2022. The Veteran's disability is rated at 40 percent since that date.

The Veteran's service-connected diabetic peripheral neuropathy of the right and left sciatic nerves, as well as his prostate cancer, are rated at specific levels prior to June 10, 2021.,Special monthly compensation (SMC) at the housebound rate is granted from August 30, 2018 to November 1, 2021.

The Veteran withdrew his appeals for service connection for asthma, a left knee disability, and the readjudication of previously denied claims for erectile dysfunction, prostate cancer, a left hip disability, and migraines.

The Veteran withdrew the appeal for both prostate cancer and benign prostate hypertrophy, resulting in the dismissal of these issues.

The Board granted a rating of 40 percent, but no higher, for prostate cancer residuals, to include voiding dysfunction, effective December 1, 2020.

The Board has granted service connection for Parkinson's disease and prostate cancer, finding that the criteria have been met under 38 C.F.R. § 3.303.

The Veteran's prostate cancer is granted as service connected due to exposure to contaminated water at Camp Lejeune during his military service.

The Veteran's claim for a higher rating for coronary artery disease (CAD) with cardiomyopathy was granted effective January 29, 2021. The Veteran's prostate cancer is rated at 20 percent and his entitlement to special monthly compensation based on housebound status was denied.

The Board has restored the 100% rating for prostate cancer to June 1, 2024. The Veteran continues to receive hormonal therapy for his condition.

The Board has decided to remand the claim of entitlement to compensation under 38 U.S.C. 1151 for prostate cancer for the period prior to August 10, 2022 due to a pre-decisional error in the previous VA medical opinion.

The Veteran's residuals of prostate cancer are rated at a 10 percent rating, but no higher, due to symptoms including marked hesitancy and weak stream.

The Board has granted the Veteran's claim for service connection for erectile dysfunction secondary to his service-connected prostate cancer, finding that the evidence is in approximate balance as to whether the erectile dysfunction was caused or aggravated by the prostate cancer.

The Board has found errors in the prior rating decision and remanded the cases of prostate cancer and bilateral hearing loss for further development to ensure proper consideration of service connection claims.

The appeal to reduce the Veteran's prostate cancer disability rating from 100% to 10% has been dismissed because it was a proposed reduction, not an appealable decision.

The Veteran's prostate cancer rating was increased to 100 percent based on active malignancy and he was granted special monthly compensation (SMC) based on 'housebound' criteria. The Board is remanding the claim for an addendum opinion to determine if the Veteran needs regular aid and attendance due to service-connected disability.

The Board has granted the Veteran's claim for service connection for urinary incontinence as secondary to his service-connected prostate cancer.

The Board has remanded the case due to a duty to assist error, requiring a VA examination and opinion regarding the relationship between the Veteran's prostate cancer and his service at Camp Lejeune.

The Veteran's claims for annual VA clothing allowances due to the use of back, right knee, left wrist, and shoulder braces have been granted. These allowances are subject to the laws and regulations governing monetary payments.

The Board has determined that the Veteran's prostate cancer is in remission and no longer active, thus reducing his disability rating from 100% to 0%. The reduction was proper as there were no local reoccurrences or metastasis of the condition. The Veteran does not have any current voiding or renal dysfunctions due to prostate cancer, so he is not entitled to a compensable rating for residuals under Diagnostic Code 7528. His erectile dysfunction is compensated through special monthly compensation.

The Veteran's claims for bilateral heavy/painful legs, type II diabetes mellitus, prostate cancer, lumbar strain (back condition), gastric neoplasm/ulcer (stomach cancer), and a chronic multi-symptom illness are being readjudicated due to the submission of new and relevant evidence.